”ADx NeuroSciences ranks among the top-3 companies worldwide in neurodegenerative biomarker development
Kevin Hrusovskyformer CEO Quanterix, USA
Access to qualified materials
Developing new antibodies is a challenging and time-consuming process. Find the materials you need in our extensive portfolio of state-of-the-art antibodies, built through in-house research and academic partnerships. This collection of qualified materials is exclusively available to our partners and collaborators.
New business opportunities.
Together with our pharma partners, we continuously develop new biomarkers for application in clinical research and clinical practice. Our IVD partners get the opportunity to develop these new biomarkers — with proven value and ready for scale-up — into kits for use in trials or as a companion diagnostic for new drugs.
Focus on quality
Our operations are focused on guaranteeing a constant supply of qualitative materials.
- Our assays are developed in accordance with state-of-the-art industry guidance ensuring their reliability and robustness;
- We are a Certified Biobank, treating patient samples with the highest regard for ethical standards
- We are working towards ISO certification of our antibody production processes documenting our consistent quality